Unresolved issues in transcatheter atrial fibrillation ablation: Silent cerebrovascular ischemias

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 2, 2013, Pages 129-131

  Anselmino, Matteo ^a   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PADGEM PROTEIN;

BLOOD CLOTTING; BRAIN ISCHEMIA; CARDIOVERSION; CATHETER ABLATION; CELL DAMAGE; ELECTRODE; FOREIGN BODY; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MULTICENTER STUDY (TOPIC); NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; THROMBUS; TRANSCATHETER ABLATION;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; MALE; PULMONARY ARTERY;

EID: 84873370816     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12018     Document Type: Note

References (17)

1. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E,: Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.
2. Schrickel JW, Lickfett L, Lewalter T, Mittman-Braun E, Selbach S, Strach K, Nahle CP, Schwab JO, Linhart M, Andriè R, Nickenig G, Sommer T,: Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace 2010; 12: 52-57.
3. Gaita F, Caponi D, Pianelli D, Scaglione M, Toso E, Cesarani F, Boffano C, Gandini G, Valentini MC, De Ponti R, Salimi F, Leclercq JF,: Radiofrequency catheter ablation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation 2010; 122: 1667-1673.
4. Gaita F, Leclercq JF, Schumacher B, Scaglione M, Toso E, Halimi F, Schade A, Froehner S, Ziegler V, Sergi D, Cesarani F, Blandino A,: Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: Comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol 2011; 22: 961-968.
5. Haeusler KG, Koch L, Herm J, Kopp UA, Heuschmann PU, Endres M, Schultheiss HP, Schirdewan A, Fiebach JB,: 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: Results of the MACPAF study. J Cardiovasc Electrophysiol 2012;doi: 10.1111/j.1540-8167.2012.02420.x.
6. Yatsu FM, Shaltoni HM,: Implications of silent strokes. Curr Atheroscler Rep 2004; 6: 307-313.
7. Di Biase L, Natale A, Blandino A, Sanchez JE, Toso E, Santangeli P, Burkhardt JD, Scaglione M, Gaita F,: Diffusion cerebral magnetic resonance imaging pre and 24 hour after catheter ablation of atrial fibrillation under therapeutic warfarin: Preliminary results. Eur Heart J 2011; 32 (Suppl): 630.
8. Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Ninomiya Y, Matsushita T, Miyata M, Hamasaki S, Tei C,: Incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation guided by complex fractionated atrial electrogram. J Cardiovasc Electrophysiol 2012; 23: 567-573.
9. Martinek M, Sigmund E, Lemes CH, Derndorfer M, Aichinger J, Winter S, Nesser HJ, Puererfellner H,: Asymptomatic cerebral lesions in pulmonary vein isolation under therapeutic anticoagulation. Eur Heart J 2012; 33 (Suppl): 669.
10. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M,: Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003; 107: 2045-2050.
11. Herrera Siklõdy C, Deneke T, Hocini M, Lehrmann H, Shin DI, Miyazaki S, Henschke S, Fluegel P, Schiebeling-Römer J, Bansmann PM, Bourdias T, Dousset V, Haïssaguerre M, Arentz T,: Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: Comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 2011; 58: 681-688.
12. Herrera Siklõdy C, Arentz T, Minners J, Jesel L, Stratz C, Valina CM, Weber R, Kalusche D, Toti F, Morel O, Trenk D,: Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: A randomized study comparing radiofrequency ablation with cryoablation. Heart Rhythm 2012; 9: 189-196.
13. Wieczorek M, Lukat M, Hoeltgen R, Condie C, Hilje T, Missler U, Hirsch J, Scharf C,: Investigation into causes of abnormal cerebral MRI findings following PVAC duty-cycled, phased RF ablation of atrial fibrillation. J Cardiovasc Electrophysiol; DOI:10.1111/j.1540-8167.2012.12006.x.
14. Anselmino M, D'Ascenzo F, Amoroso G, Ferraris F, Gaita F,: History of transcatheter atrial fibrillation ablation. J Cardiovasc Med 2012; 13: 1-8.
15. Haines DE, Stewart MT, Ahlberg S, Condie C, Fiedler GR, Halimi F, Deneke T,: Etiology of microemboli production during ablation with irrigated RF and multipolar phased RF ablation. Heart Rhythm 2012; 9: S73.
16. Nardi S, Argenziano L, De Martino G, Scaglione M, Esposito C, Borello F, Marullo F, Schiavone V, Maglia G,: Diffusion weighted MRI following phased RF ablation of AF: Low cerebral lesion rate. Heart Rhythm 2012; 9: S130.
17. Pianelli M, Scaglione M, Anselmino M, Caponi D, Garcia P, Cesarani F, Toso E, Raimondo C, Halimi F, Leclercq JF, Gaita F,: Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: A single-center pilot study. J Cardiovasc Med 2011; 12: 785-789.